Narcolepsy: Clinical Trials

4 trials for Narcolepsy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Completed 4

Follow Narcolepsy: new trials by email Literature Review of Narcolepsy trials Research Report on Narcolepsy

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Investigate the Effect of XYWAV on Sleepiness, Polysomnography, and Functional Outcomes in Participants With Idiopathic Hypersomnia or Narcolepsy
JZP258 (XYWAV) - Idiopathic Hypersomnia, Narcolepsy
Phase 4CompletedJazz Pharmaceuticals1992023-07-272026-08-27
A Switch Study From High-Sodium Oxybate to Xywav to Evaluate Changes in Blood Pressure in Participants With Narcolepsy
JZP258 - Narcolepsy
Phase 4CompletedJazz Pharmaceuticals1552023-06-262026-04-24
An Interventional Safety Switch Study (Segue Study) of XYWAV in Narcolepsy
JZP-258 - Narcolepsy
Phase 4CompletedJazz Pharmaceuticals622021-03-222024-01-09
Xyrem and Brain Dopamine in Narcolepsy
Xyrem - Narcolepsy With Cataplexy, Healthy Controls
Phase 4CompletedCentre for Addiction and Mental Health172016-01-012021-03-23

Narrower conditions

Disorders of Excessive Somnolence (1)  ·  Idiopathic Hypersomnia (1)

Broader conditions

Dyssomnias (4)  ·  Mental Disorders (4)  ·  Nervous System Diseases (4)  ·  Sleep Disorders, Intrinsic (4)  ·  Sleep Wake Disorders (4)  ·  Disorders of Excessive Somnolence (3)

Interventions

Sodium Oxybate (1)

Sponsors

Jazz Pharmaceuticals (3)  ·  Centre for Addiction and Mental Health (1)

Countries

United States (3)  ·  Canada (2)  ·  Belgium (1)  ·  France (1)  ·  Italy (1)  ·  Spain (1)

Top investigators

Stephen J Kish, Ph.D. (1)

Results publications

PMID 38652499, PMID 41090230, PMID 41831073, PMID 42060037